Oxford Cannabinoid Expands into Oncology & Discovers Promising New Treatment for Solid Tumors #octp

StockBox

10.8K subscribers

ShareSubscribe

OCTP has announced its entry into the field of oncology and the development of cannabinoid-based treatments for solid tumors. They have identified a potential immunotherapy agent that could be a first-in-class treatment. They believe that cannabinoid-based treatments can offer alternatives for various indications, including oncology, and aim to provide more convenient and cost-effective options for patients.